The 2024 NIOSH List of Hazardous Drugs introduces important changes that may affect how healthcare organizations classify, assess, and manage hazardous drugs. Its revised two-table structure emphasizes occupational hazard characteristics rather than grouping drugs primarily by therapeutic use.
This guide provides a practical roadmap to help pharmacy and healthcare leaders respond to these changes by:
- Understanding the updated NIOSH classification tables and their implications
- Determining when full USP <800> containment or an Assessment of Risk may apply
- Reviewing hazardous drug lists, policies, procedures, and formulary processes
- Reassessing workflows across receiving, storage, preparation, administration, transport, cleaning, and disposal
- Updating staff training and competency programs across affected departments
- Building a sustainable, organization-wide approach to hazardous drug safety
Whether your organization is refining an established program or responding to the updated NIOSH List, this guide can help translate current guidance into practical, sustainable action.